Article
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation
1 Jan 2001
Abstract excerpt
High-dose chemotherapy and peripheral blood stem cell transplantation (PBSCT) may accelerate telomere length loss in haematopoietic stem cells. As data including pre-and post-treatment samples are lacking, we studied leukocyte telomere length and telomerase activity before and after treatment in breast cancer patients randomized to receive 5 adjuvant courses FEC (5-FU, epirubicin and cyclophosphamide) (n = 17),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
